BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34090457)

  • 1. Patient-derived scaffolds influence secretion profiles in cancer cells mirroring clinical features and breast cancer subtypes.
    Persson E; Gregersson P; Gustafsson A; Fitzpatrick P; Rhost S; Ståhlberg A; Landberg G
    Cell Commun Signal; 2021 Jun; 19(1):66. PubMed ID: 34090457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments.
    Leiva MC; Garre E; Gustafsson A; Svanström A; Bogestål Y; Håkansson J; Ståhlberg A; Landberg G
    J Cell Physiol; 2021 Jun; 236(6):4709-4724. PubMed ID: 33368325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-derived scaffolds uncover breast cancer promoting properties of the microenvironment.
    Landberg G; Fitzpatrick P; Isakson P; Jonasson E; Karlsson J; Larsson E; Svanström A; Rafnsdottir S; Persson E; Gustafsson A; Andersson D; Rosendahl J; Petronis S; Ranji P; Gregersson P; Magnusson Y; Håkansson J; Ståhlberg A
    Biomaterials; 2020 Mar; 235():119705. PubMed ID: 31978840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Patient-Derived Scaffolds Can Expose Unique Individual Cancer Progressing Properties of the Cancer Microenvironment Associated with Clinical Characteristics.
    Garre E; Gustafsson A; Leiva MC; Håkansson J; Ståhlberg A; Kovács A; Landberg G
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features.
    Leiva MC; Gustafsson A; Garre E; Ståhlberg A; Kovács A; Helou K; Landberg G
    J Transl Med; 2023 Dec; 21(1):924. PubMed ID: 38124067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized alginate-based 3D printed scaffolds as a model of patient derived breast cancer microenvironments in drug discovery.
    Svanström A; Rosendahl J; Salerno S; Leiva MC; Gregersson P; Berglin M; Bogestål Y; Lausmaa J; Oko A; Chinga-Carrasco G; Petronis S; Standoft S; Ståhlberg A; Håkansson J; Landberg G
    Biomed Mater; 2021 Jun; 16(4):. PubMed ID: 34030145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer.
    Gustafsson A; Garre E; Leiva MC; Salerno S; Ståhlberg A; Landberg G
    Sci Rep; 2021 Jun; 11(1):13334. PubMed ID: 34172801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-induced secretion stimulates breast cancer stem cell regulatory signalling pathways.
    Jacobsson H; Harrison H; Hughes É; Persson E; Rhost S; Fitzpatrick P; Gustafsson A; Andersson D; Gregersson P; Magnusson Y; Ståhlberg A; Landberg G
    Mol Oncol; 2019 Aug; 13(8):1693-1705. PubMed ID: 31066211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived scaffolds as a model of colorectal cancer.
    Parkinson GT; Salerno S; Ranji P; Håkansson J; Bogestål Y; Wettergren Y; Ståhlberg A; Bexe Lindskog E; Landberg G
    Cancer Med; 2021 Feb; 10(3):867-882. PubMed ID: 33356003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 Induces Stem Cell Propagation through Liaison with the Sortilin-Progranulin Axis in Breast Cancer.
    Berger K; Persson E; Gregersson P; Ruiz-Martínez S; Jonasson E; Ståhlberg A; Rhost S; Landberg G
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
    Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
    Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomaterial Scaffolds as Pre-metastatic Niche Mimics Systemically Alter the Primary Tumor and Tumor Microenvironment.
    Aguado BA; Hartfield RM; Bushnell GG; Decker JT; Azarin SM; Nanavati D; Schipma MJ; Rao SS; Oakes RS; Zhang Y; Jeruss JS; Shea LD
    Adv Healthc Mater; 2018 May; 7(10):e1700903. PubMed ID: 29521008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cell-free breast cancer patient-derived scaffolds using liquid chromatography-mass spectrometry/mass spectrometry data and RNA sequencing data.
    Landberg G; Jonasson E; Gustafsson A; Fitzpatrick P; Isakson P; Karlsson J; Larsson E; Svanström A; Rafnsdottir S; Persson E; Andersson D; Rosendahl J; Petronis S; Ranji P; Gregersson P; Magnusson Y; Håkansson J; Ståhlberg A
    Data Brief; 2020 Aug; 31():105860. PubMed ID: 32637480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling.
    Segatto I; Berton S; Sonego M; Massarut S; Perin T; Piccoli E; Colombatti A; Vecchione A; Baldassarre G; Belletti B
    Oncotarget; 2014 Aug; 5(15):6267-79. PubMed ID: 25026286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion.
    Rhost S; Hughes É; Harrison H; Rafnsdottir S; Jacobsson H; Gregersson P; Magnusson Y; Fitzpatrick P; Andersson D; Berger K; Ståhlberg A; Landberg G
    Breast Cancer Res; 2018 Nov; 20(1):137. PubMed ID: 30454027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
    Chen C; Bai L; Cao F; Wang S; He H; Song M; Chen H; Liu Y; Guo J; Si Q; Pan Y; Zhu R; Chuang TH; Xiang R; Luo Y
    Oncogene; 2019 Jun; 38(23):4527-4539. PubMed ID: 30742065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human breast cancer decellularized scaffolds promote epithelial-to-mesenchymal transitions and stemness of breast cancer cells in vitro.
    Liu G; Wang B; Li S; Jin Q; Dai Y
    J Cell Physiol; 2019 Jun; 234(6):9447-9456. PubMed ID: 30478896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.
    Louie E; Nik S; Chen JS; Schmidt M; Song B; Pacson C; Chen XF; Park S; Ju J; Chen EI
    Breast Cancer Res; 2010; 12(6):R94. PubMed ID: 21067584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Metastatic Potential in a 3D Tissue Scaffold toward a Comprehensive in Vitro Model for Breast Cancer Metastasis.
    Balachander GM; Balaji SA; Rangarajan A; Chatterjee K
    ACS Appl Mater Interfaces; 2015 Dec; 7(50):27810-22. PubMed ID: 26599258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.